Next, we determined the frequencies of the possible JAK2/PD‐L1 haplotypes in a large SNP‐array‐typed MPN cohort (n = 272)27 and a population‐matched non‐MPN control cohort (n = 1620; Table S3). Here, JAK2 is linked to myeloproliferative disorder.